Notice Regarding Approval Resolution on Share Consolidation, Abolition of Unit Share System, and Partial Amendments to the Articles of Incorporation

Overview of Share Consolidation and Amendments to the Articles of Incorporation

At an extraordinary general meeting held on April 17, 2026, Hisamitsu Pharmaceutical Co., Inc. approved a proposal to consolidate ordinary shares at a ratio of 23,467,182 shares into 1 share, along with partial amendments to the Articles of Incorporation including the abolition of the unit share system. Consequently, the total number of issued shares will decrease from 70,401,547 shares to 3 shares, and the total number of authorized shares will be changed to 12 shares. The effective date of the share consolidation is scheduled for May 13, 2026.

Delisting and Impact on Shareholders

Following the share consolidation, the company’s shares will be delisted from the Tokyo Stock Exchange Prime Market, Nagoya Stock Exchange Premier Market, and Fukuoka Stock Exchange Main Market as of May 11, 2026. Trading on these markets will no longer be possible after the delisting date. Fractional shares arising from the consolidation will be purchased by the tender offeror, and the proceeds will be distributed to shareholders. Funds for purchasing these fractional shares are secured through loans from Sumitomo Mitsui Banking Corporation and Mitsubishi UFJ Bank.